한국어
Quantus

MAIA Biotechnology

MAIA · NYSE Amex
$1.32-0.75%
2026-09-04 close

MAIA Biotechnology last closed at $1.32 (-0.75%) on 2026-09-04. Listed on NYSE Amex; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

D
Overall: 건강관리 611/745 · top 82%
Factor composite · relative position in sector

PER — · PBR 13.45 — own-history percentile 39/100 · 49/100

Open self-history band
PER39/100
PBR49/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -34.56
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-34.56
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
-74.35%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 40% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About MAIA Biotechnology
What technical signals does MAIA Biotechnology (MAIA) have?
MAIA Biotechnology current technical signals: no active technical signal.
Is MAIA Biotechnology a cup-and-handle pattern?
No. MAIA Biotechnology has no valid cup-and-handle signal right now.
What are MAIA Biotechnology's financials and valuation?
MAIA Biotechnology's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy